TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer

Epigenetics Chromatin. 2024 Mar 14;17(1):6. doi: 10.1186/s13072-024-00529-7.

Abstract

Background: Prostate adenocarcinoma (PRAD) is the second leading cause of cancer-related deaths in men. High variability in DNA methylation and a high rate of large genomic rearrangements are often observed in PRAD.

Results: To investigate the reasons for such high variance, we integrated DNA methylation, RNA-seq, and copy number alterations datasets from The Cancer Genome Atlas (TCGA), focusing on PRAD, and employed weighted gene co-expression network analysis (WGCNA). Our results show that only single cluster of co-expressed genes is associated with genomic and epigenomic instability. Within this cluster, TP63 and TRIM29 are key transcription regulators and are downregulated in PRAD. We discovered that TP63 regulates the level of enhancer methylation in prostate basal epithelial cells. TRIM29 forms a complex with TP63 and together regulates the expression of genes specific to the prostate basal epithelium. In addition, TRIM29 binds DNA repair proteins and prevents the formation of the TMPRSS2:ERG gene fusion typically observed in PRAD.

Conclusion: Our study demonstrates that TRIM29 and TP63 are important regulators in maintaining the identity of the basal epithelium under physiological conditions. Furthermore, we uncover the role of TRIM29 in PRAD development.

Keywords: Epigenetic regulation; Prostate cancer; TP63; TRIM29; WGCNA.

MeSH terms

  • Chromosomal Instability
  • DNA Methylation
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Humans
  • Male
  • Prostatic Neoplasms* / metabolism
  • Regulatory Sequences, Nucleic Acid
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Tumor Suppressor Proteins / genetics

Substances

  • TRIM29 protein, human
  • DNA-Binding Proteins
  • Transcription Factors
  • TP63 protein, human
  • Tumor Suppressor Proteins